Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             66 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature Hentrich, M.
2000
11 2 p. 195-200
artikel
2 Acute myelogenous leukaemia and myelomonocytic blast crisis following polycytemia vera in HIV positive patients: Report of cases and review of the literature Hentrich, M.

11 2 p. 195-200
artikel
3 A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer Di Leo, A.
2000
11 2 p. 169-175
artikel
4 A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer Di Leo, A.

11 2 p. 169-175
artikel
5 Agreement over paclitaxel reinforces BMS monopoly
11 2 p. 124
artikel
6 Amid growing inequalities, an invitation to act
11 2 p. 125-126
artikel
7 A new strategy in unresectable metastatic colorectal cancers Giacchetti, S.
2000
11 2 p. 243-244
artikel
8 Book review Spataro, V.

11 2 p. 242
artikel
9 Book review Zanetta, G.

11 2 p. 238
artikel
10 Book review Timothy, A.

11 2 p. 130
artikel
11 Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin Greco, F. A.
2000
11 2 p. 211-215
artikel
12 Carcinoma of unknown primary site: Phase II trials with docetaxel plus cisplatin or carboplatin Greco, F.A.

11 2 p. 211-215
artikel
13 Contents of the next issue
11 2 p. v
artikel
14 Copyright
11 2 p. iii
artikel
15 Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer Levy-Piedbois, C.
2000
11 2 p. 157-161
artikel
16 Cost-effectiveness of second-line treatment with irinotecan or infusional 5-fluorouracil in metastatic colorectal cancer Levy-Piedbois, C.

11 2 p. 157-161
artikel
17 Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer Kurtz, J. E.
2000
11 2 p. 229-230
artikel
18 Dose-finding study of oral idarubicin and cyclophosphamide in first-line treatment of elderly patients with metastatic breast cancer Kurtz, J.E.

11 2 p. 229-230
artikel
19 Editorial Board
11 2 p. iv
artikel
20 E. E. Kim, E. F. Jackson (eds)., Molecular Imaging in Oncology, PET, MRI, and MRS Timothy, A.
2000
11 2 p. 130
artikel
21 F. Lawton, M. Friedlander, G. Thomas (eds)., Essentials of Gynaecological Cancer Zanetta, G.
2000
11 2 p. 238
artikel
22 Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study Tondini, C.
2000
11 2 p. 231-233
artikel
23 Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study Tondini, C.

11 2 p. 231-233
artikel
24 Guillain–Barré syndrome in a patient with non-Hodgkin's lymphoma Re, D.
2000
11 2 p. 217-220
artikel
25 Guillain-Barré syndrome in a patient with non-Hodgkin's lymphoma Re, D.

11 2 p. 217-220
artikel
26 In this issue
11 2 p. v
artikel
27 Is `one cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms Fizazi, K.
2000
11 2 p. 133-149
artikel
28 Is ‘one cycle every three or four weeks’ obsolete? A critical review of dose-dense chemotherapy in solid neoplasms Fizazi, K.

11 2 p. 133-149
artikel
29 L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure Rizzari, C.
2000
11 2 p. 189-193
artikel
30 L-asparagine depletion and L-asparaginase activity in children with acute lymphoblastic leukemia receiving i.m. or i.v. Erwinia C. or E. coli L-asparaginase as first exposure Rizzari, C.

11 2 p. 189-193
artikel
31 Low-dose continuous oral fosfestrol is highly active in `hormone-refractory' prostate cancer Orlando, M.
2000
11 2 p. 177-181
artikel
32 Low-dose continuous oral fosfestrol is highly active in 'hormone-refractory' prostate cancer Orlando, M.

11 2 p. 177-181
artikel
33 Medical errors kill more than does breast cancer
11 2 p. 126
artikel
34 Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials Bachelot, T.
2000
11 2 p. 151-156
artikel
35 Multivariable analysis of prognostic factors for toxicity and survival for patients enrolled in phase I clinical trials Bachelot, T.

11 2 p. 151-156
artikel
36 New drugs meeting in Washington: Too demanding for clinicians?
11 2 p. 123
artikel
37 New drugs meeting in Washington: Too demanding for clinicians?; Agreement over paclitaxel reinforces BMS monopoly; US relaxes pressure on developing countries regarding medications; WTO agreement could have threatened European health structures; Progress in euthanasia in Switzerland and Belgium; Amid growing inequalities, an invitation to act; Medical errors kill more than does breast cancer; Perhaps not everyone knows that... 2000
11 2 p. 123-129
artikel
38 Open label, multi-centre phase II study of raltitrexed (`Tomudex') in patients with inoperable squamous-cell carcinoma of head and neck Clarke, S. J.
2000
11 2 p. 239-241
artikel
39 Open label, multi-centre phase II study of raltitrexed (‘Tomudex’) in patients with inoperable squamous-cell carcinoma of head and neck Clarke, S.J.

11 2 p. 239-241
artikel
40 Perhaps not everyone knows that...
11 2 p. 126-129
artikel
41 Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer Krug, L. M.
2000
11 2 p. 227-228
artikel
42 Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer Krug, L.M.

11 2 p. 227-228
artikel
43 Progress in euthanasia in Switzerland and Belgium
11 2 p. 125
artikel
44 Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer Chester, J. D.
2000
11 2 p. 235-237
artikel
45 Protracted infusional 5-fluorouracil (5-FU) with bolus mitomycin in 5-FU-resistant colorectal cancer Chester, J.D.

11 2 p. 235-237
artikel
46 Randomised phase II study of cisplatin–etoposide versusinfusional carboplatin in advanced non-small-cell lung cancer and mesothelioma White, S. C.
2000
11 2 p. 201-206
artikel
47 Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma White, S.C.

11 2 p. 201-206
artikel
48 R. Brown, U. Böger-Brown (eds)., Cytotoxic Drug Resistance Mechanisms Spataro, V.
2000
11 2 p. 242
artikel
49 Recommendation for surgical treatment of colorectal liver metastascs Bozzetti, F.

11 2 p. 243
artikel
50 Recommendation for surgical treatment of colorectal liver metastases Bozzetti, F.
2000
11 2 p. 243
artikel
51 Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma Morant, R.
2000
11 2 p. 183-188
artikel
52 Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma Morant, R.

11 2 p. 183-188
artikel
53 Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma Rijnders, B.
2000
11 2 p. 221-225
artikel
54 Reversibility of paraneoplastic bilateral diaphragmatic paralysis after nephrectomy for renal cell carcinoma Rijnders, B.

11 2 p. 221-226
artikel
55 Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study Janinis, J.
2000
11 2 p. 163-167
artikel
56 Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: A Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study Janinis, J.

11 2 p. 163-167
artikel
57 Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG) Sessa, C.
2000
11 2 p. 207-210
artikel
58 Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: A study of the EORTC Early Clinical Studies Group (ECSG) Sessa, C.

11 2 p. 207-210
artikel
59 Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject Stroffolini, T.
2000
11 2 p. 244
artikel
60 Sequential development of liver cirrhosis, hepatocellular carcinoma, essential mixed cryoglobulinemia, and non-Hodgkin's lymphoma in a hepatitis C-positive subject Stroffolini, T.

11 2 p. 244
artikel
61 Table of Contents
11 2 p. ii-iii
artikel
62 The prognosis of prognostic factors in phase I clinical trials Verweij, J.
2000
11 2 p. 131-132
artikel
63 The prognosis of prognostic factors in phase I clinical trials Verweij, J.

11 2 p. 131-132
artikel
64 This letter was referred to the authors, who respond as follows: Giacchetti, S.

11 2 p. 243-244
artikel
65 US relaxes pressure on developing countries regarding medications
11 2 p. 124
artikel
66 WTO agreement could have threatened European health structures
11 2 p. 124-125
artikel
                             66 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland